diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM200236-8diaendo-7526Research ArticleСтатьиArticlesСахарный диабет и ишемическая болезнь сердца: загадка сульфаниламидовSakharnyy diabet i ishemicheskaya bolezn' serdtsa: zagadka sul'fanilamidovАлександровАндрей АлексеевичAleksandrovAndrey Alexeevich-ГУ Эндокринологический научный центр РАМН20021509200253№3 (2002)68Copyright © Александров А.А., 20022002Александров А.А.Aleksandrov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/7526

Производные сульфонилмочевины могут использоваться в лечении больных СД типа 2, не вызывая серьезных осложнений со стороны сердечнососудистой системы. Необходимо, тем не менее, помнить , что существуют клинические данные, указывающие на предпочтительность применения некоторых препаратов сульфонилмочевины у лиц с наличием ишемической болезни сердца, особенно при ее осложненном течении.

сульфаниламидысахарный диабетишемическая болезнь сердцаReferencesAmerican Diabetes Association; National Heart, Lung and Blood Institute; Juvenile Diabetes Foundation International; National Institute of Diabetes and Digestive and kidney Disease; American Heart Assotiation.//Circulation 1999; 100: 1132-1133American Diabetes Association; National Heart, Lung and Blood Institute; Juvenile Diabetes Foundation International; National Institute of Diabetes and Digestive and kidney Disease; American Heart Assotiation.//Circulation 1999; 100: 1132-1133Aschcroft FM, Gribble FM.//Diabetologia 1 999; 42: 903-91 9.Aschcroft FM, Gribble FM.//Diabetologia 1 999; 42: 903-91 9.Auchampach JA, maruyama M, Cavero I, Gross GJ. //Circulation 1992; 86: 31 1-319.Auchampach JA, maruyama M, Cavero I, Gross GJ. //Circulation 1992; 86: 31 1-319.Balkou B, Shipley M, Jarrett RJ et al. //Diabetes Care 1 998; 21; 360-7.Balkou B, Shipley M, Jarrett RJ et al. //Diabetes Care 1 998; 21; 360-7.Barrett Connor EM.//Diabetes Care 1 997;20:1 620-3.Barrett Connor EM.//Diabetes Care 1 997;20:1 620-3.Baumbach A, Braun U, Doring G, Haase KK,Voelker W, Karsch Kr.//Cardiovascular Drugs Ther 1 995; 9: 237-243.Baumbach A, Braun U, Doring G, Haase KK,Voelker W, Karsch Kr.//Cardiovascular Drugs Ther 1 995; 9: 237-243.Billman GE, Avendano CE, Halliwill JR, Burroughs JM.//Cardiovasc Pharmacol 1993; 21: 197-204.Billman GE, Avendano CE, Halliwill JR, Burroughs JM.//Cardiovasc Pharmacol 1993; 21: 197-204.Boyd AE III, Aguilar-Bryan L, Nelson DA.//Am J Med 1 996.Boyd AE III, Aguilar-Bryan L, Nelson DA.//Am J Med 1 996.Buoninconti R, Cagli V, Bossini A, DiVeroli C, DeCesaris R, Ranieri G, Rapelli A, Dessi' Fulgheri P.//Curr Ther Res 1 993; 53: 638-647.Buoninconti R, Cagli V, Bossini A, DiVeroli C, DeCesaris R, Ranieri G, Rapelli A, Dessi' Fulgheri P.//Curr Ther Res 1 993; 53: 638-647.Butler WJ, Ostrander LD, Carman WJ, Lamphiear DE.//Am J Epidemol 1985; 121:541-7Butler WJ, Ostrander LD, Carman WJ, Lamphiear DE.//Am J Epidemol 1985; 121:541-7Diabetes and Cardiovascular Disease. Time to act. International Diabetes Federation, 2001.Diabetes and Cardiovascular Disease. Time to act. International Diabetes Federation, 2001.Engler RL, Yellon DM.//Circulation 1996; 94:2297-2301. 1 3. Escande D, Cavero I. //Trends Pharmacol Sci 1 992; 1 3: 269-271.Engler RL, Yellon DM.//Circulation 1996; 94:2297-2301. 1 3. Escande D, Cavero I. //Trends Pharmacol Sci 1 992; 1 3: 269-271.Frampton J, Buckley MM, Fitton A.//Drugs 1 992;44: 625-655. 1 5. Fuller JH,Shipley MJ,Rose G, Jarrett RJ,Keen H.//BMJ 1 983; 287: 867-70.Frampton J, Buckley MM, Fitton A.//Drugs 1 992;44: 625-655. 1 5. Fuller JH,Shipley MJ,Rose G, Jarrett RJ,Keen H.//BMJ 1 983; 287: 867-70.Galie N et al.,//Fm J Cardiol 1 990; 65: 343-348.Galie N et al.,//Fm J Cardiol 1 990; 65: 343-348.Gross GJ.//Current Patients Ltd. ISSN 0961-4680, 191, KCM-B82KSM-B90.Gross GJ.//Current Patients Ltd. ISSN 0961-4680, 191, KCM-B82KSM-B90.Gross GJ, Auchampach JA.//Circ Res 1 992; 70: 223-233. 1 9. Hariwer ADB, Clarke BF. //Br Med J 1 976; 1:1 26-1 28.Gross GJ, Auchampach JA.//Circ Res 1 992; 70: 223-233. 1 9. Hariwer ADB, Clarke BF. //Br Med J 1 976; 1:1 26-1 28.Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. //NEJM 1 998; 339:229-234.Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. //NEJM 1 998; 339:229-234.Immamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, Takeshita A.//Am J Physiol 1992; 263: H399-H404.Immamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, Takeshita A.//Am J Physiol 1992; 263: H399-H404.Kantor PF, Coetzee WA, Carmeliet EE, Dennis SC, Opie LH.//Circ Res 1990; 66: 478-485.Kantor PF, Coetzee WA, Carmeliet EE, Dennis SC, Opie LH.//Circ Res 1990; 66: 478-485.Klein R.//Diabetes Care 1 995; 18: 258-68Klein R.//Diabetes Care 1 995; 18: 258-68Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, Harris S, Burger W. //Eur Heart J 1999; 20:439-446.Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, Harris S, Burger W. //Eur Heart J 1999; 20:439-446.Kondo T, Kubota I, Tachibana H, Yamaki M, Tomoike H.//Cardiovasc Res 1996; 31: 683-7.Kondo T, Kubota I, Tachibana H, Yamaki M, Tomoike H.//Cardiovasc Res 1996; 31: 683-7.Kubota I, Yamaki M, Shibata T, Ikeno E, Hosoya Y, Tomoike H.//Circulation 1993; 88 (part I): 1845-1851.Kubota I, Yamaki M, Shibata T, Ikeno E, Hosoya Y, Tomoike H.//Circulation 1993; 88 (part I): 1845-1851.Kuusisto J, Mykkanen L, Pyorala K, Laakso M.//Diabetes 1994;43: 960-7.Kuusisto J, Mykkanen L, Pyorala K, Laakso M.//Diabetes 1994;43: 960-7.Lomuscio A, Vergani D, Marano L, Castagnone M, Fiorentini C.//Cor Art Dis 1994; 5: 767-771.Lomuscio A, Vergani D, Marano L, Castagnone M, Fiorentini C.//Cor Art Dis 1994; 5: 767-771.Miettinen H, Lehto S, Salomaa W et al.//Diabetes Care 1998; 21: 69-75.Miettinen H, Lehto S, Salomaa W et al.//Diabetes Care 1998; 21: 69-75.Murakami M, et al. //Cardiovasc. Drug Ther. 1989; 3 (suppl.2): 614-61 9.Murakami M, et al. //Cardiovasc. Drug Ther. 1989; 3 (suppl.2): 614-61 9.Murry CE, Jennings RB, Reimer KA. //Circulation 1 986; 74: 1 1 24-1 1 36.Murry CE, Jennings RB, Reimer KA. //Circulation 1 986; 74: 1 1 24-1 1 36.Nichols CG, Lederer WJ. //Am J Physiol 1 991; 261 :H 1 675HI 686.)Nichols CG, Lederer WJ. //Am J Physiol 1 991; 261 :H 1 675HI 686.)Noma A.//Nature 1983; 305:147-148.Noma A.//Nature 1983; 305:147-148.O'Keefe JH, Blackstone EH, Sergeant P, McCallister BD. //Eur Heart J 1998; 19:1696-1703.O'Keefe JH, Blackstone EH, Sergeant P, McCallister BD. //Eur Heart J 1998; 19:1696-1703.Освольд БУ, Ионсбю M, Грилл В.//Научный журнал Союза врачей Северной Европы 2000; 21: 2560-2564.Освольд БУ, Ионсбю M, Грилл В.//Научный журнал Союза врачей Северной Европы 2000; 21: 2560-2564.Pan WH, Cedres Lb, Lui К et al. //Am J Epidemiol 1986; 123: 504-51 6.Pan WH, Cedres Lb, Lui К et al. //Am J Epidemiol 1986; 123: 504-51 6.Pitt B, Segal R, martines FA et al.//Lancet 1 997; 349: 747-75.Pitt B, Segal R, martines FA et al.//Lancet 1 997; 349: 747-75.Purcell H, Fox K.//Br J Clin Pharmacol 1993; 47:1-5.Purcell H, Fox K.//Br J Clin Pharmacol 1993; 47:1-5.Schulz R, Rose J, Martin C, heusch G.//Circulation 1993; 88 (part 2): 1-102.Schulz R, Rose J, Martin C, heusch G.//Circulation 1993; 88 (part 2): 1-102.Soler NG, Bennett MA, Pentecost BL, Fitzgerald M. //Q J Med 1 975; 1 7.Soler NG, Bennett MA, Pentecost BL, Fitzgerald M. //Q J Med 1 975; 1 7.The Bypass Angioplasty Investigation (BARI).//Circulation 1 997; 96: 1761-1769.The Bypass Angioplasty Investigation (BARI).//Circulation 1 997; 96: 1761-1769.The University group Diabetes Program. Part II: Mortality results. Diabetes 1979; 19:787-830.The University group Diabetes Program. Part II: Mortality results. Diabetes 1979; 19:787-830.Toombs CF, Moore TL, Shebuski RJ. //Cardiovasc Res 1 993; 27: 617-622.Toombs CF, Moore TL, Shebuski RJ. //Cardiovasc Res 1 993; 27: 617-622.UK Prospective Diabetes Study (UKPDS) Group. //Lancet 1998;352:837-53.UK Prospective Diabetes Study (UKPDS) Group. //Lancet 1998;352:837-53.Ulvenstam G, Alberg A, Bergstrand R, Johansson S, Wilhelmsen L.//Diabetes 1985; 34: 787-792.Ulvenstam G, Alberg A, Bergstrand R, Johansson S, Wilhelmsen L.//Diabetes 1985; 34: 787-792.Wukstrom G, Malmberg K, Ryden L.//Eur Heart J 1999; 20: 402-405Wukstrom G, Malmberg K, Ryden L.//Eur Heart J 1999; 20: 402-405

The authors declare that there are no conflicts of interest present.